Increased PD-1 Expression and Altered T Cell Repertoire Diversity Predict Mortality in Patients with Septic Shock: A Preliminary Study

被引:35
|
作者
Tomino, Atsutoshi [1 ]
Tsuda, Masanobu [1 ]
Aoki, Ruri [1 ]
Kajita, Yuka [1 ]
Hashiba, Masamitsu [1 ]
Terajima, Tsuguaki [1 ]
Kano, Hideki [1 ]
Takeyama, Naoshi [1 ]
机构
[1] Aichi Med Univ, Dept Emergency & Crit Care Med, Aichi, Japan
来源
PLOS ONE | 2017年 / 12卷 / 01期
关键词
INFLAMMATORY RESPONSE; IMMUNE DYSFUNCTIONS; DR EXPRESSION; HLA-DR; SEPSIS; IMMUNOSUPPRESSION; INFECTION; IMMUNOTHERAPY; LIGANDS; TIME;
D O I
10.1371/journal.pone.0169653
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Sepsis causes impairment of innate and adaptive immunity by multiple mechanisms, including depletion of immune effector cells and T cell exhaustion. Although lymphocyte dysfunction is associated with increased mortality and potential reactivation of latent viral infection in patients with septic shock, the relation between viral reactivation and lymphocyte dysfunction is obscure. The objectives of this study were 1) to determine the relation of lymphocyte dysfunction to viral reactivation and mortality, and 2) to evaluate recovery of lymphocyte function during septic shock, including T cell receptor (TCR) diversity and the expression of programmed death 1 (PD-1). In 18 patients with septic shock and latent cytomegalovirus (CMV) infection, serial blood samples were obtained on days 1, 3, and 7 after the onset of shock, and immune cell subsets and receptor expression were characterized by flow cytometry. TCR diversity of peripheral blood mononuclear cells was analyzed by Multi-N-plex PCR, and CMV DNA was quantified using a real-time PCR kit. A decrease of TCR diversity and monocyte HLA-DR expression were observed in the early stage of septic shock, while CD4+ T cells displayed an increase of PD-1 expression. Significant lymphopenia persisted for at least 7 days following the onset of septic shock. Normalization of TCR diversity and PD-1 expression was observed by day 7, except in patients who died. CMV reactivation was detected in 3 of the 18 patients during the first week of their ICU stay and all 3 patients died. These changes are consistent with the early stage of immune cell exhaustion and indicate the importance of normal lymphocyte function for recovery from septic shock. Ongoing lymphocyte dysfunction is associated with CMV reactivation and dissemination, as well as with unfavorable outcomes.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients
    Kozako, T.
    Yoshimitsu, M.
    Fujiwara, H.
    Masamoto, I.
    Horai, S.
    White, Y.
    Akimoto, M.
    Suzuki, S.
    Matsushita, K.
    Uozumi, K.
    Tei, C.
    Arima, N.
    LEUKEMIA, 2009, 23 (02) : 375 - 382
  • [42] PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients
    T Kozako
    M Yoshimitsu
    H Fujiwara
    I Masamoto
    S Horai
    Y White
    M Akimoto
    S Suzuki
    K Matsushita
    K Uozumi
    C Tei
    N Arima
    Leukemia, 2009, 23 : 375 - 382
  • [43] Peripheral blood T-cell receptor repertoire as a predictor of clinical outcomes in gastrointestinal cancer patients treated with PD-1 inhibitor
    S. Ji
    J. Li
    L. Chang
    C. Zhao
    R. Jia
    Z. Tan
    R. Liu
    Y. Zhang
    Y. Li
    G. Yin
    Y. Guan
    X. Xia
    X. Yi
    J. Xu
    Clinical and Translational Oncology, 2021, 23 : 1646 - 1656
  • [44] Peripheral blood T-cell receptor repertoire as a predictor of clinical outcomes in gastrointestinal cancer patients treated with PD-1 inhibitor
    Ji, S.
    Li, J.
    Chang, L.
    Zhao, C.
    Jia, R.
    Tan, Z.
    Liu, R.
    Zhang, Y.
    Li, Y.
    Yin, G.
    Guan, Y.
    Xia, X.
    Yi, X.
    Xu, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (08): : 1646 - 1656
  • [45] TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction
    Vredevoogd, David W.
    Apriamashvili, Georgi
    Levy, Pierre L.
    Sinha, Sanju
    Huinen, Zowi R.
    Visser, Nils L.
    de Bruijn, Beaunelle
    Boshuizen, Julia
    van Hal-van Veen, Susan E.
    Ligtenberg, Maarten A.
    Bleijerveld, Onno B.
    Lin, Chun-Pu
    Diaz-Gomez, Judit
    Sanchez, Santiago Duro
    Markovits, Ettai
    Nieto, Juan Simon
    van Vliet, Alex
    Krijgsman, Oscar
    Markel, Gal
    Besser, Michal J.
    Altelaar, Maarten
    Ruppin, Eytan
    Peeper, Daniel S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [46] Reconstitution of Monocyte Subsets and PD-L1 Expression but Not T Cell PD-1 Expression in Obstructive Sleep Apnea Patients upon PAP Therapy
    Polasky, Christina
    Steffen, Armin
    Loyal, Kristin
    Lange, Christian
    Bruchhage, Karl-Ludwig
    Pries, Ralph
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [47] Novel T cell exhaustion marker to predict monotherapy PD-1 compared to combination CTLA-4 and PD-1 response in melanoma.
    Loo, Kimberly
    Tsai, Katy K.
    Pauli, Mariela
    Sandoval, Priscila Munoz
    Alvarado, Michael
    Algazi, Alain Patrick
    Rosenblum, Michael
    Daud, Adil
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade
    Yan, Cihui
    Ma, Xiaoxue
    Guo, Zhoubo
    Wei, Xiaoying
    Han, Dong
    Zhang, Tian
    Chen, Xi
    Cao, Fuliang
    Dong, Jie
    Zhao, Gang
    Gao, Xuan
    Wang, Tao
    Jiang, Yao
    Wang, Ping
    Pang, Qingsong
    Zhang, Wencheng
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [49] T cell apoptosis signaling biomarker of PD-1 engagement in cancer patients
    Zhao, Wei
    Dong, Haidong
    CANCER RESEARCH, 2014, 74 (19)
  • [50] Increased Activation and Function but also Increased T cell Loss from Activation Induced Cell Death by PD-1 Inhibition
    Sheng, Michael
    Vick, Logan
    Collins, Craig
    Yoon, Daniel
    Murphy, William
    Blazar, Bruce
    Tuscano, Joseph
    Orentas, Rimas
    Xiong, Ying
    Mason, Nicola
    Nielsen, Ryan
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):